Molecular Diagnosis of Lung Cancer
作者： Lucian R. Chirieac , Philip T. Cagle
DOI: 10.1007/978-1-4614-3197-8_9
关键词: Epidermal growth factor receptor 、 Cancer 、 Anaplastic lymphoma kinase 、 Pharmacogenomics 、 Gene 、 Drug 、 Treatment of lung cancer 、 Bioinformatics 、 Lung cancer 、 Medicine
摘要: Discoveries in molecular pathogenetic mechanisms have had a major impact the field of pulmonary disease, with important implications for screening, diagnosis, and treatment lung cancer. Novel diagnostic techniques are being developed, new therapeutic approaches actively investigated. Molecular biology has profound effects on development products, including vaccines, agents, novel gene therapies, is basis pharmacogenomics, study genes or chromosomal loci that involved determining responsiveness an individual to particular drug.
springer.com
springerlink.com参考文章(56)
Jennifer Baldwin, Lucian R. Chirieac, Amit Dutt, Tim Fennell, Megan Hanna, Bruce E. Johnson, Robert C. Onofrio, Roman K. Thomas, Giovanni Tonon, Barbara A. Weir, Xiaojun Zhao, Liuda Ziaugra, Michael C. Zody, Thomas Giordano, Mark B. Orringer, Jack A. Roth, Margaret R. Spitz, Ignacio I. Wistuba, Bradley Ozenberger, Peter J. Good, Andrew C. Chang, David G. Beer, Mark A. Watson, Marc Ladanyi, Stephen Broderick, Akihiko Yoshizawa, William D. Travis, William Pao, Michael A. Province, George M. Weinstock, Harold E. Varmus, Stacey B. Gabriel, Eric S. Lander, Richard A. Gibbs, Matthew Meyerson, Richard K. Wilson, Li Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M. Muzny, Margaret B. Morgan, Lucinda Fulton, Robert S. Fulton, Qunyuan Zhang, Michael C. Wendl, Michael S. Lawrence, David E. Larson, Ken Chen, David J. Dooling, Aniko Sabo, Alicia C. Hawes, Hua Shen, Shalini N. Jhangiani, Lora R. Lewis, Otis Hall, Yiming Zhu, Tittu Mathew, Yanru Ren, Jiqiang Yao, Steven E. Scherer, Kerstin Clerc, Ginger A. Metcalf, Brian Ng, Aleksandar Milosavljevic, Manuel L. Gonzalez-Garay, John R. Osborne, Rick Meyer, Xiaoqi Shi, Yuzhu Tang, Daniel C. Koboldt, Ling Lin, Rachel Abbott, Tracie L. Miner, Craig Pohl, Ginger Fewell, Carrie Haipek, Heather Schmidt, Brian H. Dunford-Shore, Aldi Kraja, Seth D. Crosby, Christopher S. Sawyer, Tammi Vickery, Sacha Sander, Jody Robinson, Wendy Winckler, Somatic mutations affect key pathways in lung adenocarcinoma Nature. ,vol. 455, pp. 1069- 1075 ,(2008) , 10.1038/NATURE07423
Mary Beth Beasley, Elisabeth Brambilla, William D. Travis, The 2004 World Health Organization classification of lung tumors. Seminars in Roentgenology. ,vol. 40, pp. 90- 97 ,(2005) , 10.1053/J.RO.2005.01.001
Lynette M. Sholl, Beow Y. Yeap, A. John Iafrate, Alison J. Holmes-Tisch, Yi-Ping Chou, Ming-Tsang Wu, Yih-Gang Goan, Li Su, Elisa Benedettini, Jian Yu, Massimo Loda, Pasi A. Jänne, David C. Christiani, Lucian R. Chirieac, Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Research. ,vol. 69, pp. 8341- 8348 ,(2009) , 10.1158/0008-5472.CAN-09-2477
Jussi P. Koivunen, Craig Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits, Alison J. Holmes, Hwan Geun Choi, Jhingook Kim, Derek Chiang, Roman Thomas, Jinseon Lee, William G. Richards, David J. Sugarbaker, Christopher Ducko, Neal Lindeman, J. Paul Marcoux, Jeffrey A. Engelman, Nathanael S. Gray, Charles Lee, Matthew Meyerson, Pasi A. Jänne, EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer Clinical Cancer Research. ,vol. 14, pp. 4275- 4283 ,(2008) , 10.1158/1078-0432.CCR-08-0168
Klarisa Rikova, Ailan Guo, Qingfu Zeng, Anthony Possemato, Jian Yu, Herbert Haack, Julie Nardone, Kimberly Lee, Cynthia Reeves, Yu Li, Yerong Hu, Zhiping Tan, Matthew Stokes, Laura Sullivan, Jeffrey Mitchell, Randy Wetzel, Joan MacNeill, Jian Min Ren, Jin Yuan, Corey E. Bakalarski, Judit Villen, Jon M. Kornhauser, Bradley Smith, Daiqiang Li, Xinmin Zhou, Steven P. Gygi, Ting-Lei Gu, Roberto D. Polakiewicz, John Rush, Michael J. Comb, Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer Cell. ,vol. 131, pp. 1190- 1203 ,(2007) , 10.1016/J.CELL.2007.11.025
E. L. Kwak, R. Sordella, D. W. Bell, N. Godin-Heymann, R. A. Okimoto, B. W. Brannigan, P. L. Harris, D. R. Driscoll, P. Fidias, T. J. Lynch, S. K. Rabindran, J. P. McGinnis, A. Wissner, S. V. Sharma, K. J. Isselbacher, J. Settleman, D. A. Haber, Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 7665- 7670 ,(2005) , 10.1073/PNAS.0502860102
Giuseppe Giaccone, Clinical impact of novel treatment strategies Oncogene. ,vol. 21, pp. 6970- 6981 ,(2002) , 10.1038/SJ.ONC.1205565
L Lamant, F Meggetto, T al Saati, L Brugieres, BB de Paillerets, N Dastugue, A Bernheim, H Rubie, MJ Terrier-Lacombe, A Robert, F Rigal, D Schlaifer, M Shiuta, S Mori, G Delsol, High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining Blood. ,vol. 87, pp. 284- 291 ,(1996) , 10.1182/BLOOD.V87.1.284.284
Roy S. Herbst, John V. Heymach, Scott M. Lippman, Molecular origins of cancer: Lung cancer The New England Journal of Medicine. ,vol. 359, pp. 1367- 1380 ,(2008) , 10.1056/NEJMRA0802714
William D. Travis, Pathology and genetics of tumours of the lung , pleura, thymus and heart Published in <b>2004</b> in Lyon by IARC. ,(2004)